ARNA Arena Pharmaceuticals, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

ARNA [NASD]

Arena Pharmaceuticals, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	4.30	EPS (ttm)	11.56	Insider Own	0.10%	Shs Outstand	49.92M	Perf Week	4.99%
Market Cap	2.48B	Forward P/E	-	EPS next Y	-5.75	Insider Trans	-69.43%	Shs Float	49.76M	Perf Month	-2.72%
Income	593.10M	PEG	-	EPS next Q	-1.32	Inst Own	86.00%	Short Float	6.44%	Perf Quarter	-20.32%
Sales	814.30M	P/S	3.05	EPS this Y	78.80%	Inst Trans	0.38%	Short Ratio	7.17	Perf Half Y	8.92%
Book/sh	24.19	P/B	2.05	EPS next Y	-168.90%	ROA	60.70%	Target Price	69.00	Perf Year	22.58%
Cash/sh	20.16	P/C	2.46	EPS next 5Y	-	ROE	66.20%	52W Range	31.97 - 64.48	Perf YTD	27.55%
Dividend	-	P/FCF	4.03	EPS past 5Y	7.40%	ROI	-5.20%	52W High	-23.26%	Beta	1.53
Dividend %	-	Quick Ratio	-	Sales past 5Y	-26.10%	Gross Margin	-	52W Low	54.79%	ATR	1.56
Employees	194	Current Ratio	36.50	Sales Q/Q	-75.00%	Oper. Margin	70.70%	RSI (14)	54.85	Volatility	2.54% 3.48%
Optionable	Yes	Debt/Eq	0.04	EPS Q/Q	-91.40%	Profit Margin	72.80%	Rel Volume	0.38	Prev Close	49.68
Shortable	Yes	LT Debt/Eq	0.04	Earnings	Nov 06 AMC	Payout	0.00%	Avg Volume	447.10K	Price	49.49
Recom	1.80	SMA20	5.61%	SMA50	-2.09%	SMA200	-3.30%	Volume	159,471	Change	-0.39%

Dec-13-18

Initiated

Berenberg

Buy

$55

May-31-18

Initiated

RBC Capital Mkts

Outperform

$65

Mar-21-18

Upgrade

Needham

Hold → Buy

$60

Mar-20-18

Reiterated

JMP Securities

Mkt Outperform

$63 → $79

Jan-18-18

Resumed

Credit Suisse

Outperform

$44

Jan-18-18

Initiated

Credit Suisse

Outperform

$44

Jan-03-18

Upgrade

Wells Fargo

Market Perform → Outperform

Jul-11-17

Reiterated

Citigroup

Buy

$23 → $37

Jul-07-17

Upgrade

JMP Securities

Mkt Perform → Mkt Outperform

Jun-27-17

Initiated

Citigroup

Buy

$23

May-19-17

Initiated

Leerink Partners

Outperform

Sep-15-16

Initiated

FBR & Co.

Outperform

Mar-01-16

Reiterated

RBC Capital Mkts

Sector Perform

$2 → $1.50

Nov-11-15

Reiterated

RBC Capital Mkts

Sector Perform

$5 → $2

Oct-28-15

Reiterated

WallachBeth

Buy

$6 → $4

May-12-15

Reiterated

WallachBeth

Buy

$8 → $6

Jan-23-15

Initiated

RBC Capital Mkts

Sector Perform

Aug-07-14

Reiterated

WallachBeth

Buy

$9 → $8

Nov-15-13

Initiated

WallachBeth

Buy

Oct-03-13

Initiated

Cowen

Market Perform

$4.50

Oct-18-19 03:01AM	Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community PR Newswire
Oct-05-19 09:51AM	What Kind Of Shareholder Owns Most Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock? Simply Wall St.
Sep-30-19 07:20PM	Top Marijuana Stocks on the NASDAQ Investopedia
Sep-26-19 08:30AM	Arena Pharmaceuticals Presented New Data from the Phase 2 OASIS trial for Etrasimod at the World Congress of Gastroenterology Meeting PR Newswire -6.14%
Sep-25-19 08:30AM	Arena Pharmaceuticals to Present at the Cantor Global Healthcare Conference on October 2 PR Newswire
Sep-17-19 08:30AM	Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual Meeting PR Newswire
Sep-12-19 11:25AM	United Therapeutics' Trevyent NDA for PAH Accepted by FDA Zacks
Sep-10-19 11:15PM	Arena Pharmaceuticals Inc (ARNA) EVP, General Counsel & Sec Steven W Spector Sold $2. ... GuruFocus.com
Sep-09-19 08:30AM	Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting PR Newswire
Sep-05-19 11:23AM	Does Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) CEO Salary Compare Well With Others? Simply Wall St.
Aug-28-19 08:30AM	Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire
Aug-13-19 12:44PM	25 Biggest Marijuana Companies in the World Insider Monkey
Aug-08-19 04:47PM	Edited Transcript of ARNA earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents -7.77%
04:08PM	This Biotech Crashed On 'Erroneous' Report Plus 2 Stocks That Diverged Investor's Business Daily
10:34AM	Arena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues Meet Zacks
04:23AM	Arena Pharmaceuticals Inc (ARNA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 04:01PM	Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials PR Newswire
Aug-06-19 03:50PM	Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A High Quality Stock To Own? Simply Wall St.
Aug-01-19 09:49AM	United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y Zacks
Jul-31-19 08:30AM	Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7 PR Newswire
Jul-29-19 10:34AM	Analysts Estimate Arena Pharmaceuticals (ARNA) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-25-19 09:00AM	Arena Pharmaceuticals (ARNA) Upgraded to Buy: Here's Why Zacks
08:30AM	Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome PR Newswire
Jul-09-19 01:32PM	Should Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Be Your Next Stock Pick? Simply Wall St.
Jun-18-19 12:30PM	A Company's First Profit Can Mean Big Profits for Investors Zacks
10:38AM	Arena Initiates Dosing in Pivotal Colitis Study on Etrasimod Zacks
Jun-17-19 08:30AM	Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis PR Newswire
Jun-14-19 06:29PM	Did Hedge Funds Drop The Ball On Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey
Jun-13-19 06:29PM	Edited Transcript of ARNA earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
08:30AM	Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19 PR Newswire
Jun-07-19 09:30AM	Why Is Arena Pharmaceuticals (ARNA) Up 9.1% Since Last Earnings Report? Zacks
Jun-06-19 12:32PM	Does Market Volatility Impact Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) Share Price? Simply Wall St.
May-21-19 07:30AM	Corvidia Therapeutics Announces Dr. Preston Klassen Joins its Board of Directors PR Newswire
May-17-19 08:30AM	Arena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community PR Newswire
May-13-19 09:00AM	All You Need to Know About Arena Pharmaceuticals (ARNA) Rating Upgrade to Buy Zacks -6.14%
08:30AM	Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire
May-10-19 07:45PM	Arena Pharmaceuticals Inc (ARNA) Q1 2019 Earnings Call Transcript Motley Fool
07:04AM	Did Business Growth Power Arena Pharmaceuticals's (NASDAQ:ARNA) Share Price Gain of 226%? Simply Wall St.
May-09-19 04:24PM	S&P 500, Nasdaq end lower for fourth day after Trump claims China broke the deal MarketWatch
09:03AM	Arena Pharmaceuticals' (ARNA) Loss Widens in Q1 But Stock Up Zacks
May-08-19 04:46PM	Arena Pharmaceutical shares slide after drug maker reports disappointing financial results MarketWatch
04:01PM	Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2019 Financial Results PR Newswire
May-02-19 09:26AM	United Therapeutics (UTHR) Down Despite Q1 Earnings Beat Zacks
May-01-19 08:30AM	Arena Pharmaceuticals to Release First Quarter 2019 Financial Results and Provide Corporate Update on May 8 PR Newswire
Apr-30-19 02:50PM	Heres What Hedge Funds Think About Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey
Apr-24-19 11:30AM	The New Cannabis ETF Is Already Making Additions Benzinga
Apr-03-19 11:52AM	What Type Of Shareholder Owns Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA)? Simply Wall St.
08:30AM	Arena Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 10 PR Newswire
Mar-28-19 09:30AM	Why Is Arena Pharmaceuticals (ARNA) Down 10.1% Since Last Earnings Report? Zacks
Mar-26-19 07:30AM	New Research Coverage Highlights The Blackstone Group, Arena Pharmaceuticals, Arrow Electronics, AdvanSix, KBR, and RPM International Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Mar-18-19 03:36PM	These 3 Cannabis Stocks Are Set to Skyrocket, Say Analysts SmarterAnalyst
Mar-08-19 08:30AM	Arena Pharmaceuticals Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th Congress of European Crohn's and Colitis Organisation PR Newswire
Mar-01-19 06:55AM	Edited Transcript of ARNA earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 10:16AM	United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates Zacks
Feb-27-19 08:25AM	Arena Pharmaceuticals (ARNA) Beats on Q4 Earnings & Revenues Zacks
Feb-26-19 08:52PM	Arena Pharmaceuticals Inc (ARNA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM	Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results PR Newswire
Feb-25-19 03:25PM	5 Clinical-Stage Biotech Stocks to Buy InvestorPlace
Feb-21-19 08:30AM	Arena Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference on February 27 PR Newswire
Feb-20-19 04:01PM	Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2018 Financial Results and Provide Corporate Update on February 26 PR Newswire
Feb-15-19 09:05AM	Top 3 Marijuana Stocks on the NASDAQ Investopedia
Feb-07-19 04:30PM	Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn's & Colitis Congress PR Newswire
Jan-30-19 10:23AM	Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A Financially Strong Company? Simply Wall St.
07:55AM	Research Report Identifies Cameco, American Equity Investment Life Holding, AG Mortgage Investment Trust, Arena Pharmaceuticals, Mimecast, and Aldeyra Therapeutics with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-25-19 07:38AM	The Daily Biotech Pulse: Intuitive Surgical Earnings, Corbus To Offer Shares, Eton In-Licenses Neurologic Drug Benzinga
Jan-24-19 08:00PM	United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag PR Newswire
08:00PM	Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag PR Newswire
Jan-10-19 07:00AM	Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and ACADIA Pharmaceuticals ACCESSWIRE
Jan-07-19 08:30AM	Arena Pharmaceuticals Reports Positive Long-Term Data from the Open-Label Extension of the Phase 2 OASIS Trial Evaluating Etrasimod for Treatment of Ulcerative Colitis PR Newswire +6.91%
Dec-19-18 08:30AM	Arena Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 10 PR Newswire
Dec-17-18 08:30AM	Arena Pharmaceuticals Appoints Experienced Life Sciences Industry Finance Executive Manmeet S. Soni to Board of Directors PR Newswire -6.72%
Dec-13-18 10:05PM	Is Arena Pharmaceuticals, Inc. (ARNA) A Good Stock To Buy? Insider Monkey
06:55AM	Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and China Biologic Products Holdings ACCESSWIRE
Dec-10-18 12:09PM	What Did Arena Pharmaceuticals Incs (NASDAQ:ARNA) CEO Take Home Last Year? Simply Wall St.
Dec-06-18 06:50AM	Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and Sarepta Therapeutics ACCESSWIRE
Nov-27-18 07:35AM	Research Report Identifies Cheniere Energy Partners, LP, Arena Pharmaceuticals, Geron, Keysight Technologies, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, and Casella Waste with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
05:00AM	Analysts: Why United Therapeutics has had a streak of licensing deals American City Business Journals
Nov-26-18 08:30AM	Arena Pharmaceuticals Expands Senior Management Team to Support Commercialization and Medical Affairs PR Newswire
Nov-23-18 12:58PM	2 New Small Cap ETFs on the Block Zacks
Nov-21-18 11:30AM	Opioid Alternatives Could Make Investors Major Gains ACCESSWIRE
11:21AM	Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal Zacks
Nov-20-18 08:30AM	Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire
Nov-17-18 03:53PM	Edited Transcript of ARNA earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
08:31AM	My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy Motley Fool
Nov-16-18 09:11AM	Arena (ARNA) Out-Licenses Rights to PAH Drug, Stock Up 22% Zacks +5.39%
07:00AM	Todays Research Reports on Stocks to Watch: Arena Pharmaceuticals and Sonoma Pharmaceuticals ACCESSWIRE
Nov-15-18 04:30PM	Why Arena Pharmaceuticals, Smart & Final Stores, and Tilray Jumped Today Motley Fool +21.62%
03:38PM	Stocks on the move: JP Morgan shares increase as Walmart beat estimates but shy on revenue Yahoo Finance Video
12:33PM	Why Arena Pharmaceuticals Stock Is Soaring Today InvestorPlace
11:05AM	Here's Why Arena Pharmaceuticals Jumped as Much as 30.6% Today Motley Fool
09:58AM	4 Stocks To Watch As Investors Dump Tech; Head To Healthcare ACCESSWIRE
07:33AM	United Therapeutics to develop, sell Arena Pharma's hypertension treatment Reuters
07:00AM	Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag PR Newswire
Nov-13-18 08:30AM	Arena Pharmaceuticals Presented Preclinical Data for APD418 in Development for Treatment of Decompensated Heart Failure at American Heart Association Scientific Sessions PR Newswire
Nov-09-18 10:22AM	Arena Pharmaceuticals (ARNA) Beats on Q3 Earnings and Sales Zacks
Nov-07-18 04:01PM	Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2018 Financial Results PR Newswire
02:58PM	Arena Pharmaceuticals: Don't Fight the Tape or Jim Cramer's Evaluation TheStreet.com
Oct-31-18 08:30AM	Arena Pharmaceuticals to Release Third Quarter 2018 Financial Results and Provide Corporate Update on November 7 PR Newswire
Oct-30-18 10:33AM	Analysts Estimate Arena Pharmaceuticals (ARNA) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-15-18 09:20AM	Factors of Influence in 2018, Key Indicators and Opportunity within Meritor, Fred's, Arena Pharmaceuticals, AMERISAFE, Accelerate Diagnostics, and NextEra Energy New Research Emphasizes Economic Growth GlobeNewswire

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include ralinepag (APD811), which is in Phase III trial to treat pulmonary arterial hypertension; etrasimod (APD334) for ulcerative colitis, and Crohn's disease, as well as for atopic dermatitis and other indications; and Olorinab (APD371), which is in Phase II trial for the treatment of gastrointestinal pain. It is also developing APD418, a calcium-independent myofilament derepressor for the treatment of decompensated heart failure. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Axovant Sciences GmbH; Outpost Medicine LLC; CY Biotech Company Limited; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SPECTOR STEVEN W	EVP, General Counsel & Sec	Oct 14	Option Exercise	0.00	6,300	0	15,990	Oct 16 08:22 PM
Lisicki Robert	EVP, Chief Commercial Officer	Oct 14	Option Exercise	0.00	6,300	0	6,300	Oct 16 08:21 PM
Klassen Preston	EVP and CMO	Oct 14	Option Exercise	0.00	6,300	0	6,300	Oct 16 08:20 PM
Aurentz Vincent	Executive VP and CBO	Oct 14	Option Exercise	0.00	9,000	0	9,000	Oct 16 08:19 PM
Lind Kevin Robert	Executive VP and CFO	Oct 14	Option Exercise	0.00	6,300	0	6,548	Oct 16 08:18 PM
Munshi Amit	President and CEO	Oct 14	Option Exercise	0.00	11,700	0	19,450	Oct 16 08:17 PM
SPECTOR STEVEN W	EVP, General Counsel & Sec	Sep 10	Option Exercise	15.50	12,627	195,719	22,317	Sep 10 09:03 PM
SPECTOR STEVEN W	EVP, General Counsel & Sec	Sep 10	Sale	50.28	12,627	634,873	9,690	Sep 10 09:03 PM
SPECTOR STEVEN W	EVP, General Counsel & Sec	Sep 09	Option Exercise	18.74	21,457	402,186	41,147	Sep 10 09:03 PM
Aurentz Vincent	Executive VP and CBO	Sep 09	Option Exercise	25.25	65,000	1,641,500	65,000	Sep 10 09:05 PM
Aurentz Vincent	Executive VP and CBO	Sep 09	Sale	50.72	65,000	3,296,700	0	Sep 10 09:05 PM
SPECTOR STEVEN W	EVP, General Counsel & Sec	Sep 09	Sale	50.72	31,457	1,595,515	9,690	Sep 10 09:03 PM
Soni Manmeet Singh	Director	Jun 14	Sale	55.89	1,217	68,022	5,087	Jun 17 06:53 PM
FETZER OLIVER	Director	Jun 14	Sale	55.89	1,525	85,238	4,179	Jun 17 06:41 PM
Dallas Jayson Donald Alexander	Director	Jun 14	Sale	55.90	1,525	85,240	4,179	Jun 17 06:38 PM
Nova Tina Susan	Director	Mar 07	Option Exercise	40.10	1,200	48,120	12,676	Mar 08 06:15 PM
Nova Tina Susan	Director	Mar 07	Sale	45.99	1,200	55,183	11,476	Mar 08 06:15 PM
Klassen Preston	EVP and CMO	Jan 08	Option Exercise	15.10	3,000	45,300	3,000	Jan 08 09:04 PM
Klassen Preston	EVP and CMO	Jan 08	Sale	44.00	3,000	132,000	0	Jan 08 09:04 PM
Klassen Preston	EVP and CMO	Jan 07	Option Exercise	15.10	16,000	241,600	16,000	Jan 08 09:04 PM
Klassen Preston	EVP and CMO	Jan 07	Sale	41.69	16,000	667,066	0	Jan 08 09:04 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience